Histone methyltransferase SETDB1: a common denominator of tumorigenesis with therapeutic potential D Strepkos, M Markouli, A Klonou, AG Papavassiliou, C Piperi Cancer Research 81 (3), 525-534, 2021 | 58 | 2021 |
Insights in the immunobiology of glioblastoma D Strepkos, M Markouli, A Klonou, C Piperi, AG Papavassiliou Journal of Molecular Medicine 98, 1-10, 2020 | 51 | 2020 |
Targeting of endoplasmic reticulum (ER) stress in gliomas M Markouli, D Strepkos, AG Papavassiliou, C Piperi Pharmacological research 157, 104823, 2020 | 50 | 2020 |
Structure, activity and function of the SETDB1 protein methyltransferase M Markouli, D Strepkos, C Piperi Life 11 (8), 817, 2021 | 31 | 2021 |
Prominent role of histone modifications in the regulation of tumor metastasis M Markouli, D Strepkos, EK Basdra, AG Papavassiliou, C Piperi International journal of molecular sciences 22 (5), 2778, 2021 | 26 | 2021 |
Epigenetic mechanisms regulate sex-specific bias in disease manifestations S Chlamydas, M Markouli, D Strepkos, C Piperi Journal of Molecular Medicine 100 (8), 1111-1123, 2022 | 19 | 2022 |
Histone lysine methyltransferase SETDB1 as a novel target for central nervous system diseases M Markouli, D Strepkos, S Chlamydas, C Piperi Progress in Neurobiology 200, 101968, 2021 | 18 | 2021 |
Resistance to CDK4/6 inhibition: Mechanisms and strategies to overcome a therapeutic problem in the treatment of hormone receptor-positive metastatic breast cancer MC Papadimitriou, A Pazaiti, K Iliakopoulos, M Markouli, V Michalaki, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1869 (12), 119346, 2022 | 17 | 2022 |
Bivalent genes targeting of glioma heterogeneity and plasticity M Markouli, D Strepkos, KA Papavassiliou, AG Papavassiliou, C Piperi International Journal of Molecular Sciences 22 (2), 540, 2021 | 10 | 2021 |
Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options D Strepkos, M Markouli, KA Papavassiliou, AG Papavassiliou, C Piperi Neuropathology and Applied Neurobiology 48 (2), e12762, 2022 | 9 | 2022 |
Toxicity profile of chimeric antigen receptor T-cell and bispecific antibody therapies in multiple myeloma: pathogenesis, prevention and management M Markouli, F Ullah, S Unlu, N Omar, N Lopetegui-Lia, M Duco, F Anwer, ... Current Oncology 30 (7), 6330-6352, 2023 | 6 | 2023 |
Crosstalk of epigenetic and metabolic signaling underpinning glioblastoma pathogenesis M Markouli, D Strepkos, KA Papavassiliou, AG Papavassiliou, C Piperi Cancers 14 (11), 2655, 2022 | 6 | 2022 |
Deciphering glioma epitranscriptome: focus on RNA modifications C Piperi, M Markouli, AN Gargalionis, KA Papavassiliou, ... Oncogene 42 (28), 2197-2206, 2023 | 5 | 2023 |
Recent advances in adult post-transplant lymphoproliferative disorder M Markouli, F Ullah, N Omar, A Apostolopoulou, P Dhillon, ... Cancers 14 (23), 5949, 2022 | 5 | 2022 |
Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies M Markouli, D Strepkos, C Piperi International journal of molecular sciences 23 (21), 13657, 2022 | 5 | 2022 |
Advances on liquid biopsy analysis for glioma diagnosis P Skouras, M Markouli, T Kalamatianos, G Stranjalis, P Korkolopoulou, ... Biomedicines 11 (9), 2371, 2023 | 3 | 2023 |
Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review F Anagnostakis, M Kokkorakis, M Markouli, C Piperi International Journal of Molecular Sciences 24 (11), 9393, 2023 | 2 | 2023 |
Fertility potential in 5α-reductase type 2 deficient males M Markouli, L Michala Journal of Pediatric Urology 19 (1), 108-114, 2023 | 2 | 2023 |
Advances on Epigenetic Drugs for Pediatric Brain Tumors P Skouras, M Markouli, D Strepkos, C Piperi Current Neuropharmacology 21 (7), 1519, 2023 | 1 | 2023 |
Glioma Cells Expressing High Levels of ALDH5A1 Exhibit Enhanced Migration Transcriptional Signature in Patient Tumors C Piperi, MS Saurty-Seerunghen, G Levidou, A Sepsa, EA Trigka, ... Neurotherapeutics 20 (3), 881-895, 2023 | 1 | 2023 |